Vimarsana
Biggest News Aggregation in the World

Rare Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rare Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rare Genetics Today - Breaking & Trending Today

Takeda Showcases Digital Health Solutions at G20 Meeting in India - Vimarsana News

Takeda Showcases Digital Health Solutions at G20 Meeting in India

Takeda Showcases Digital Health Solutions at G20 Meeting in India : Rashtra News Takeda Biopharmaceuticals India Private Limited Showcased Digital Innovations - MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting The Three-Day Meeting was Held in Goa, India, from April 17th to April 19th, 2023, and Side Event was Focused on: ‘Citizen-Centric

Takeda Enters Into Two-Year Contract with Canadian Blood Services for GLASSIA®, Treatment for Rare form of Emphysema - Takeda Pharmaceutical (NYSE:TAK) - Vimarsana News

Takeda Enters Into Two-Year Contract with Canadian Blood Services for GLASSIA®, Treatment for Rare form of Emphysema - Takeda Pharmaceutical (NYSE:TAK)

Availability of GLASSIA® represents significant milestone for patients with emphysema due to severe hereditary deficiency of Alpha-1 antitrypsin TORONTO, Dec. 20, 2023 /CNW/ - Takeda Canada Inc. (Takeda) has

Takeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases - Vimarsana News

Takeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases

Company to Feature 17 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology Hematology Presentations Include New Data from the Phase 3 and Continuation Trials Supporting...

New Campaign Celebrates Canadian Rare Disease Changemakers - Vimarsana News

New Campaign Celebrates Canadian Rare Disease Changemakers

/CNW/ - Today, 13 Canadian rare disease organizations, in partnership with Takeda Canada Inc. ("Takeda",) unite to launch I Am Number 12, to raise awareness of...

The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE) - Vimarsana News

The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)

/PRNewswire/ -- Takeda (TSE:4502/NYSE:TAK) today announced the European Commission has approved TAKHZYRO® (lanadelumab) for the routine prevention of recurrent...